Timing of Bisphosphonate (Alendronate) Initiation after Surgery for Fragility Fracture: A Population-Based Cohort Study

Bisphosphonates are used as first-line treatment for the prevention of fragility fracture (FF); they act by inhibiting osteoclast-mediated bone resorption. The timing of their administration after FF surgery is controversial; thus, we compared the incidence of second FF, surgery for second FF, and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Meng-Huang, Lin, Yu-Sheng, Wu, Christopher, Lee, Ching-Yu, Chen, Yi-Chia, Huang, Tsung-Jen, Cheng, Jur-Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229144/
https://www.ncbi.nlm.nih.gov/pubmed/34201202
http://dx.doi.org/10.3390/jcm10122541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229144/
https://www.ncbi.nlm.nih.gov/pubmed/34201202
http://dx.doi.org/10.3390/jcm10122541

Ejemplares similares